{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T18:12:16Z","timestamp":1774462336079,"version":"3.50.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.tiv.2023.105608","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T11:57:59Z","timestamp":1683201479000},"page":"105608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Telomere loss is accompanied by decreased pool of shelterin proteins TRF2 and RAP1, elevated levels of TERRA and enhanced glycolysis in imatinib-resistant CML cells"],"prefix":"10.1016","volume":"90","author":[{"given":"Anna","family":"Deregowska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Lewinska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Warzybok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Stoklosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"Wnuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2023.105608_bb0005","first-page":"9","article-title":"Do all roads lead to the Rome? The glycation perspective! Semin. Cancer Biol.","volume":"49","author":"Ahmad","year":"2018"},{"key":"10.1016\/j.tiv.2023.105608_bb0010","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1242\/jcs.019372","article-title":"Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress","volume":"121","author":"Ahmed","year":"2008","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.tiv.2023.105608_bb0015","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1007\/s00018-021-03783-0","article-title":"Non-canonical roles of canonical telomere binding proteins in cancers","volume":"78","author":"Akincilar","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.tiv.2023.105608_bb0020","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13257","article-title":"Autophagic receptor p62 protects against glycation-derived toxicity and enhances viability","volume":"19","author":"Aragon\u00e8s","year":"2020","journal-title":"Aging Cell"},{"key":"10.1016\/j.tiv.2023.105608_bb0025","doi-asserted-by":"crossref","first-page":"15833","DOI":"10.18632\/aging.203203","article-title":"The lack of functional DNMT2\/TRDMT1 gene modulates cancer cell responses during drug-induced senescence","volume":"13","author":"Bloniarz","year":"2021","journal-title":"Aging"},{"key":"10.1016\/j.tiv.2023.105608_bb0030","doi-asserted-by":"crossref","first-page":"37747","DOI":"10.1074\/jbc.M105796200","article-title":"Gleevec (STI571) influences metabolic enzyme activities and glucose carbon flow toward nucleic acid and fatty acid synthesis in myeloid tumor cells","volume":"276","author":"Boren","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tiv.2023.105608_bb0035","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1080\/15384101.2015.1100771","article-title":"Rap1 induces cytokine production in pro-inflammatory macrophages through NF\u03baB signaling and is highly expressed in human atherosclerotic lesions","volume":"14","author":"Cai","year":"2015","journal-title":"Cell Cycle Georget. Tex"},{"key":"10.1016\/j.tiv.2023.105608_bb0040","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrc2981","article-title":"Regulation of cancer cell metabolism","volume":"11","author":"Cairns","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tiv.2023.105608_bb0045","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1186\/1471-2407-11-512","article-title":"Regulation of hTERT by BCR-ABL at multiple levels in K562 cells","volume":"11","author":"Chai","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tiv.2023.105608_bb0050","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1080\/13880209.2021.1944224","article-title":"Cryptotanshinone enhances the efficacy of Bcr-Abl tyrosine kinase inhibitors via inhibiting STAT3 and eIF4E signalling pathways in chronic myeloid leukaemia","volume":"59","author":"Cheng","year":"2021","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.tiv.2023.105608_bb0055","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1101\/gad.1346005","article-title":"Shelterin: the protein complex that shapes and safeguards human telomeres","volume":"19","author":"de Lange","year":"2005","journal-title":"Genes Dev."},{"key":"10.1016\/j.tiv.2023.105608_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/genes11101145","article-title":"Differential regulation of telomeric complex by BCR-ABL1 kinase in human cellular models of chronic myeloid leukemia-from single cell analysis to next-generation sequencing","volume":"11","author":"Deregowska","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.tiv.2023.105608_bb0065","doi-asserted-by":"crossref","DOI":"10.1007\/s00432-023-04662-w","article-title":"The interplay between telomeric complex members and BCR::ABL1 oncogenic tyrosine kinase in the maintenance of telomere length in chronic myeloid leukemia","author":"Der\u0119gowska","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.tiv.2023.105608_bb0070","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41580-020-00314-w","article-title":"Cellular senescence in ageing: from mechanisms to therapeutic opportunities","volume":"22","author":"Di Micco","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tiv.2023.105608_bb0075","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.111","article-title":"Apoptosis and autophagy have opposite roles on imatinib-induced K562 leukemia cell senescence","volume":"3","author":"Drullion","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tiv.2023.105608_bb0080","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1080\/10428190410001693542","article-title":"Telomere shortening correlates with prognostic score at diagnosis and proceeds rapidly during progression of chronic myeloid leukemia","volume":"45","author":"Drummond","year":"2004","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.tiv.2023.105608_bb0085","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41586-020-2815-6","article-title":"RAD51-dependent recruitment of TERRA lncRNA to telomeres through R-loops","volume":"587","author":"Feretzaki","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.tiv.2023.105608_bb0090","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.canlet.2009.11.017","article-title":"p21(Cip1) confers resistance to imatinib in human chronic myeloid leukemia cells","volume":"292","author":"Ferrandiz","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tiv.2023.105608_bb0095","doi-asserted-by":"crossref","first-page":"15571","DOI":"10.1074\/jbc.C100055200","article-title":"Stable association of hsp90 and p23, but not hsp70, with active human telomerase","volume":"276","author":"Forsythe","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tiv.2023.105608_bb0100","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification","volume":"293","author":"Gorre","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.tiv.2023.105608_bb0105","doi-asserted-by":"crossref","first-page":"6661","DOI":"10.1158\/1078-0432.CCR-04-0039","article-title":"Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells","volume":"10","author":"Gottschalk","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tiv.2023.105608_bb0110","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.canlet.2019.11.017","article-title":"Human telomerase reverse transcriptase depletion potentiates the growth-inhibitory activity of imatinib in chronic myeloid leukemia stem cells","volume":"469","author":"Grandjenette","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tiv.2023.105608_bb0115","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of Cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.tiv.2023.105608_bb0120","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/glycob\/cwz073","article-title":"Advanced glycation end products (AGEs), protein aggregation and their cross talk: new insight in tumorigenesis","volume":"30","author":"Haque","year":"2020","journal-title":"Glycobiology"},{"key":"10.1016\/j.tiv.2023.105608_bb0125","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0092-8674(93)90499-G","article-title":"The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases","volume":"75","author":"Harper","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.tiv.2023.105608_bb0130","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1038\/sj.leu.2402741","article-title":"Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy","volume":"16","author":"Hochhaus","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.tiv.2023.105608_bb0135","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nsmb.3083","article-title":"Control of telomerase action at human telomeres","volume":"22","author":"Hockemeyer","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.tiv.2023.105608_bb0140","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1101\/gad.13.7.817","article-title":"Functional requirement of p23 and Hsp90 in telomerase complexes","volume":"13","author":"Holt","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.tiv.2023.105608_bb0145","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/gcc.22171","article-title":"Relevance of telomere\/telomerase system impairment in early stage chronic lymphocytic leukemia: telomere\/telomerase system impairment in CLL","volume":"53","author":"Hoxha","year":"2014","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.tiv.2023.105608_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2014.00009","article-title":"Differential effects of glycation on protein aggregation and amyloid formation","volume":"1","author":"Iannuzzi","year":"2014","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.tiv.2023.105608_bb0155","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/sj.leu.2403257","article-title":"P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate","volume":"18","author":"Illmer","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.tiv.2023.105608_bb0160","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/ajh.26642","article-title":"Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoring","volume":"97","author":"Jabbour","year":"2022","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.tiv.2023.105608_bb0165","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.semcancer.2017.05.008","article-title":"Hypoxia driven glycation: mechanisms and therapeutic opportunities","volume":"49","author":"Khan","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.tiv.2023.105608_bb0170","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1476-5381.2009.00345.x","article-title":"Metabolic characteristics of imatinib resistance in chronic myeloid leukaemia cells","volume":"158","author":"Klawitter","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tiv.2023.105608_bb0175","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1158\/1078-0432.CCR-08-3291","article-title":"Abnormalities in glucose uptake and metabolism in imatinib-resistant human BCR-ABL-positive cells","volume":"15","author":"Kominsky","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tiv.2023.105608_bb0180","article-title":"AMP-activated protein kinase activation primes cytoplasmic translocation and autophagic degradation of the BCR-ABL protein in CML cells","volume":"cas.14698","author":"Koyama","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.tiv.2023.105608_bb0185","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.achaem.2017.06.002","article-title":"Genomic landscape of human erythroleukemia K562 cell line, as determined by next-generation sequencing and cytogenetics","volume":"48","author":"Kurkowiak","year":"2017","journal-title":"Acta Haematol. Pol."},{"key":"10.1016\/j.tiv.2023.105608_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101337","article-title":"AMPK-mediated senolytic and senostatic activity of quercetin surface functionalized Fe3O4 nanoparticles during oxidant-induced senescence in human fibroblasts","volume":"28","author":"Lewinska","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.tiv.2023.105608_bb0195","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41420-022-00991-w","article-title":"Modulation of energy metabolism to overcome drug resistance in chronic myeloid leukemia cells through induction of autophagy","volume":"8","author":"Li","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tiv.2023.105608_bb0200","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1210\/clinem\/dgab703","article-title":"High hemoglobin glycation index is associated with telomere attrition independent of HbA1c, mediated by TNF\u03b1","volume":"107","author":"Lyu","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tiv.2023.105608_bb0205","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1182\/blood.V96.3.1070","article-title":"Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance","volume":"96","author":"Mahon","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.tiv.2023.105608_bb0210","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/ncb2081","article-title":"Mammalian Rap1 controls telomere function and gene expression through binding to telomeric and extratelomeric sites","volume":"12","author":"Martinez","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tiv.2023.105608_bb0215","doi-asserted-by":"crossref","first-page":"999","DOI":"10.15252\/embr.201541708","article-title":"TERRA promotes telomerase-mediated telomere elongation in Schizosaccharomyces pombe","volume":"17","author":"Moravec","year":"2016","journal-title":"EMBO Rep."},{"key":"10.1016\/j.tiv.2023.105608_bb0220","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1080\/15384101.2016.1160976","article-title":"CDKIs p18(INK4c) and p57(Kip2) are involved in quiescence of CML leukemic stem cells after treatment with TKI","volume":"15","author":"Moreno-Lorenzana","year":"2016","journal-title":"Cell Cycle Georget. Tex"},{"key":"10.1016\/j.tiv.2023.105608_bb0225","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.exphem.2009.10.005","article-title":"Effect of imatinib on the signal transduction cascade regulating telomerase activity in K562 (BCR-ABL-positive) cells sensitive and resistant to imatinib","volume":"38","author":"Mor-Tzuntz","year":"2010","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.tiv.2023.105608_bb0230","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1093\/nar\/gkx184","article-title":"Trypanosoma brucei RAP1 maintains telomere and subtelomere integrity by suppressing TERRA and telomeric RNA:DNA hybrids","volume":"45","author":"Nanavaty","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tiv.2023.105608_bb0235","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4149\/neo_2009_05_393","article-title":"WT1 expression in peripheral leukocytes of patients with chronic myeloid leukemia serves for the prediction of imatinib resistance","volume":"56","author":"Otahalova","year":"2009","journal-title":"Neoplasma"},{"key":"10.1016\/j.tiv.2023.105608_bb0240","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1038\/sj.onc.1209597","article-title":"Glycolysis inhibition for anticancer treatment","volume":"25","author":"Pelicano","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.tiv.2023.105608_bb0245","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1172\/JCI41246","article-title":"Chronic myeloid leukemia: mechanisms of blastic transformation","volume":"120","author":"Perrotti","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tiv.2023.105608_bb0250","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.freeradbiomed.2019.11.024","article-title":"Proteasomal degradation of glycated proteins depends on substrate unfolding: preferred degradation of moderately modified myoglobin","volume":"152","author":"Raupbach","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tiv.2023.105608_bb0255","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3390\/cancers5031086","article-title":"Dynamic length changes of telomeres and their nuclear organization in chronic myeloid leukemia","volume":"5","author":"Samassekou","year":"2013","journal-title":"Cancers"},{"key":"10.1016\/j.tiv.2023.105608_bb0260","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1756-8722-6-26","article-title":"Presence of alternative lengthening of telomeres associated circular extrachromosome telomere repeats in primary leukemia cells of chronic myeloid leukemia","volume":"6","author":"Samassekou","year":"2013","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.tiv.2023.105608_bb0265","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1474-9728.2004.00124.x","article-title":"Mitochondrial hTERT exacerbates free-radical-mediated mtDNA damage: mitochondrial telomerase","volume":"3","author":"Santos","year":"2004","journal-title":"Aging Cell"},{"key":"10.1016\/j.tiv.2023.105608_bb0270","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2165\/00129785-200505050-00002","article-title":"Detection of resistance to imatinib by metabolic profiling: clinical and drug development implications","volume":"5","author":"Serkova","year":"2005","journal-title":"Am. J. Pharmacogenomics"},{"key":"10.1016\/j.tiv.2023.105608_bb0275","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/j.bbadis.2014.06.018","article-title":"Extra-nuclear telomerase reverse transcriptase (TERT) regulates glucose transport in skeletal muscle cells","volume":"1842","author":"Shaheen","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tiv.2023.105608_bb0280","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.4161\/cc.3.11.1229","article-title":"BCR\/ABL recruits p53 tumor suppressor protein to induce drug resistance","volume":"3","author":"Stoklosa","year":"2004","journal-title":"Cell Cycle"},{"key":"10.1016\/j.tiv.2023.105608_bb0285","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/ncb2080","article-title":"Telomere-independent Rap1 is an IKK adaptor and regulates NF-kappaB-dependent gene expression","volume":"12","author":"Teo","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tiv.2023.105608_bb0290","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1038\/sj.bjc.6602592","article-title":"Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell lines","volume":"92","author":"Uziel","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.tiv.2023.105608_bb0295","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-014-0061-9","article-title":"The role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantation","volume":"7","author":"Wang","year":"2014","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.tiv.2023.105608_bb0300","doi-asserted-by":"crossref","first-page":"316","DOI":"10.7150\/ijbs.10528","article-title":"Role of TERRA in the regulation of telomere length","volume":"11","author":"Wang","year":"2015","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.tiv.2023.105608_bb0305","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11357-013-9541-z","article-title":"Changes in DNA methylation patterns and repetitive sequences in blood lymphocytes of aged horses","volume":"36","author":"Wnuk","year":"2014","journal-title":"Age (Dordr.)"},{"key":"10.1016\/j.tiv.2023.105608_bb0310","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/leu.2012.222","article-title":"Gab2 signaling in chronic myeloid leukemia cells confers resistance to multiple Bcr-Abl inhibitors","volume":"27","author":"W\u00f6hrle","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.tiv.2023.105608_bb0315","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.celrep.2013.05.032","article-title":"Nontelomeric role for Rap1 in regulating metabolism and protecting against obesity","volume":"3","author":"Yeung","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.tiv.2023.105608_bb0320","doi-asserted-by":"crossref","first-page":"38908","DOI":"10.18632\/oncotarget.7676","article-title":"The sweet trap in tumors: aerobic glycolysis and potential targets for therapy","volume":"7","author":"Yu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.tiv.2023.105608_bb0325","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s13238-019-0610-7","article-title":"Telomere-dependent and telomere-independent roles of RAP1 in regulating human stem cell homeostasis","volume":"10","author":"Zhang","year":"2019","journal-title":"Protein Cell"},{"key":"10.1016\/j.tiv.2023.105608_bb0330","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1038\/onc.2010.67","article-title":"Imatinib resistance associated with BCR-ABL upregulation is dependent on HIF-1\u03b1-induced metabolic reprograming","volume":"29","author":"Zhao","year":"2010","journal-title":"Oncogene"}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233323000577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233323000577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:43:02Z","timestamp":1760136182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233323000577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":66,"alternative-id":["S0887233323000577"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2023.105608","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Telomere loss is accompanied by decreased pool of shelterin proteins TRF2 and RAP1, elevated levels of TERRA and enhanced glycolysis in imatinib-resistant CML cells","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2023.105608","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105608"}}